Vitamin K in the treatment and prevention of osteoporosis and arterial calcification

American Journal of Health-System Pharmacy

Volumn 62, Issue 15, 2005, Pages 1574-1581

  Adams, Jamie ^a   Pepping, Joseph ^b  

^a Castle Medical Center   (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

Calcinosis; Combined therapy; Dosage; Drug interactions; Estrogens; Mechanism of action; Menaquinone; Osteoporosis; Phytonadione; Toxicity; Vitamin D; Vitamins

Indexed keywords

4 CARBOXYGLUTAMIC ACID; BLOOD CLOTTING FACTOR; CALCIUM; FIBRINOGEN; GLUTAMIC ACID; HORMONE; HYDROXYAPATITE; MAGNESIUM; MENAQUINONE; MENATETRENONE; OSTEOCALCIN; PARATHYROID HORMONE; PHYTOMENADIONE; PROTEIN; PROTHROMBIN; RAPESEED OIL; SOYBEAN OIL; VITAMIN D; VITAMIN K GROUP; WARFARIN; ZINC;

ARTERY CALCIFICATION; BONE DENSITY; BONE METABOLISM; CLINICAL TRIAL; DRUG POTENTIATION; FRACTURE; HUMAN; NONHUMAN; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; TOXICITY; VITAMIN K DEFICIENCY;

EID: 23044457384     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp040357     Document Type: Review

References (66)

1. Weber P. Vitamin K and bone health. Nutrition. 2001; 17:880-7.
2. Melton LJ III. How many women have osteoporosis now? J Bone Miner Res. 1995; 10:175.
3. Wallin R, Wajih N, Greenwood GT et al. Arterial calcification: a review of mechanisms, animal models, and the prospects for therapy. Med Res Rev. 2001; 21:274-301.
4. Arad Y, Spadaro LA, Goodman K et al. Predictive value of electron beam computed tomography of the coronary arteries: 19-month follow-up of 1173 asymptomatic subjects. Circulation. 1996; 93:1951-3.
5. Barengolts EI, Berman M, Kukreja SC et al. Osteoporosis and coronary atherosclerosis in asymptomatic postmenopausal women. Calcif Tissue Int. 1998; 62:209-13.
6. Hak AE, Pols HA, van Hemert AM et al. Progression of aortic calcification is associated with metacarpal bone loss during menopause: a population-based longitudinal study. Arterioscler Thromb Vasc Biol. 2000; 20:1926-31.
7. Jie KS, Bots ML, Vermeer C et al. Vitamin K intake and osteocalcin levels in women with and without aortic atherosclerosis: a population-based study. Atherosclerosis. 1995; 116:117-23.
8. Jie KS, Bots ML, Vermeer C et al. Vitamin K status and bone mass in women with and without aortic atherosclerosis: a population-based study. Calcif Tissue Int. 1996; 59:352-6.
9. Matsunaga S, Ito H, Sakou T. The effect of vitamin K and D supplementation on ovariectomy-induced bone loss. Calcif Tissue Int. 1999; 65:285-9.
10. Hauschka PV, Carr SA. Calcium-dependent α-helical structure in osteocalcin. Biochemistry. 1982; 21:2538-47.
11. Price PA. Gla-containing proteins of bone. Connect Tissue Res. 1989; 21:51-60.
12. Iwamoto J, Takeda T, Ichimura S. Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis. J Orthop Sci. 2000; 5:546-51.
13. Price PA. Vitamin K-dependent formation of bone Gla protein (osteocalcin) and its function. Vitam Horm. 1985; 42: 65-108.
14. Luo G, Ducy P, McKee MD et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature. 1997; 386:78-81.
15. Yagami K, Suh JY, Enomoto-Iwamoto M et al. Matrix GLA protein is a developmental regulator of chondrocyte mineralization and, when constitutively expressed, blocks endochondral and intramembranous ossification in the limb. J Cell Biol. 1999; 147:1097-108.
16. Braam LA, Dissel P, Gijsbers BL et al. Assay for human matrix GIa protein in serum. Arteriosder Thromb Vasc Biol. 2000; 20:1257-61.
17. Shanahan CM, Proudfoot D, Farzaneh-Far A et al. The role of Gla proteins in vascular calcification. Crit Rev Eukaryot Gene Expr. 1998; 8:357-75.
18. Price PA, Faus SA, Williamson MK. Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arteriosder Thromb Vasc Biol. 1998; 18:1400-7.
19. Vermeer C, Gijsbers BL, Craciun AM et al. Effects of vitamin K on bone mass and bone metabolism. J Nutr. 1996; 126(4 suppl):1187S-91S.
20. Schurgers LJ, Vermeer C. Differential lipoprotein transport pathways of K-vitamins in healthy subjects. Biochim Biophys Acta. 2002; 1570:27-32.
21. Vermeer C, Braam L. Role of K vitamins in the regulation of tissue calcification. J Bone Miner Metab. 2001; 19:201-6.
22. Lipsky JJ. Nutritional sources of vitamin K. Mayo Clin Proc. 1994; 69:462-6.
23. Suttie IW. The importance of menaquinones in human nutrition. Annu Rev Nutr. 1995; 15:399-417.
24. Berkner KL. The vitamin K-dependent carboxylase. J Nutr. 2000; 130:1877-80.
25. 2+ on the structure of vitamin K-dependent coagulation factors. Haemostasis. 1996; 26:45-53.
26. Vermeer C. Gamma-carboxyglutamate-containing proteins and the vitamin K-dependent carboxylase. Biochem J. 1990; 266:625-36.
27. Suttie JW. Synthesis of vitamin K-dependent proteins. FASEB J. 1993; 7: 445-52.
28. Furie B, Bouchard BA, Furie BC. Vitamin K-dependent biosynthesis of γ-carboxyglutamic acid. Blood. 1999; 93:1798-808.
29. Binkley NC, Krueger DC, Engelke JA et al. Vitamin K supplementation reduces serum concentrations of under-gamma-carboxylated osteocalcin in healthy young and elderly adults. Am J Clin Nutr. 2000; 72:1523-8.
30. Sokoll LI, Sadowski IA. Comparison of biochemical indexes for assessing vitamin K nutritional status in a healthy adult population. Am J Clin Nutr. 1996; 63: 566-73.
31. Sokoll LI, Booth SL, O'Brien ME et al. Changes in serum osteocalcin, plasma phylloquinone, and urinary γ-carboxyglutamic acid in response to altered intakes of dietary phylloquinone in human subjects. Am J Clin Nutr. 1997; 65:779-84.
32. Binkley NC, Krueger DC, Kawahara TN et al. A high phylloquinone intake is required to achieve maximal osteocalcin gamma-carboxylation. Am J Clin Nutr. 2002; 76:1055-60.
33. Booth SL, Martini L, Peterson JW et al. Dietary phylloquinone depletion and repletion in older women. J Nutr. 2003; 133:2565-9.
34. 2 vitamin D3-induced mineralization in human periosteal osteoblasts. Calcif Tissue Int. 1996; 59:466-73.
35. Koshihara Y, Hoshi K, Okawara R et al. Vitamin K stimulates osteoblastogenesis and inhibits osteoclastogenesis in human bone marrow cell culture. J Endocrinol. 2003; 176:339-48.
36. Braam LA, Knapen MH, Geusens P et al. Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age. Calcif Tissue Int. 2003; 73:21-6
37. 2, vitamin D, and calcium on the bone metabolism of rats in the growth phase. J Orthop Sci. 2002; 7:364-9.
38. Feskanish D, Weber P, Willett WC et al. Vitamin K intake and hip fractures in women: a prospective study. Am J Clin Nutr. 1999; 69:74-9.
39. Booth SL, Tucker KL, Chen H et al. Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women. Am J Clin Nutr. 2000; 71:1201-8.
40. Vergnaud P, Garnero P, Meunier PJ et al. Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS study. J Clin Endocrinol Metab. 1997; 82:719-24.
41. Szulc P, Chapuy MC, Meunier PJ et al. Serum Undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest. 1993; 91:1769-74.
42. Szulc P, Chapuy MC, Meunier PJ et al. Serum Undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study. Bone. 1996; 18:487-8.
43. Knapen MH, Nieuwenhuijzen Kruseman AC, Wouters RS et al. Correlation of serum osteocalcin fractions with bone mineral density in women during the first 10 years after menopause. Calcif Tissue Int. 1998; 63:375-9.
44. 1 supplementation of Dutch postmenopausal women with normal and low bone mineral densities: effects on serum 25-hydroxyvitamin D and carboxylated osteocalcin. Eur J Clin Nutr. 2000; 54:626-31.
45. Hodges SJ, Pilkington MJ, Stamp TC et al. Depressed levels of circulating menaquinones in patients with osteoporotic fractures of the spine and femoral neck. Bone. 1991; 12:387-9.
46. Shiraki M, Shiraki Y, Aoki C et al. Vitamin K, (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res. 2000; 15:515-21.
47. Miki T, Nakatsuka K, Naka H et al. Vitamin K2 (menaquinone 4) reduces serum Undercarboxylated osteocalcin level as early as 2 weeks in elderly women with established osteoporosis. J Bone Miner Metab. 2003; 21:161-5.
48. Douglas AS, Robins SP, Hutchison JD et al. Carboxylation of osteocalcin in postmenopausal osteoporotic women following vitamin K and D supplementation. Bone. 1995; 17:15-20.
49. Takahashi M, Naitou K, Ohishi T et al. Effect of vitamin K and/or D on under-carboxylated and intact osteocalcin in osteoporotic patients with vertebral or hip fractures. Clin Endocrinol. 2001; 54:219-24.
50. Iwamoto J, Takeda T, Ichimura S. Treatment with vitamin D3 and/or vitamin K2 for postmenopausal osteoporosis. Keio J Med. 2003; 52:147-50.
51. 3, parathyroid hormone, and glucocorticoids. Metab Bone Dis Relat Res. 1984; 5:229-34.
52. 3 on osteocalcin in postmenopausal osteoporosis. Calcif Tissue Int. 1986; 38:328-32.
53. 3 circulating levels in bone disorders in rats. Endocrinology. 1987; 120:2123-30.
54. Hidaka T, Hasegawa T, Fujimura M et al. Treatment for patients with postmenopausal osteoporosis who have been placed on HRT and show a decrease in bone mineral density: effects of concomitant administration of vitamin K2. J Bone Miner Metab. 2002; 20:235-9.
55. National Institutes of Health. Vitamin K and bone turnover in postmenopausal women, www.clinicaltrials.gov/ct/show/ NCT00062595?order=11 (accessed 2004 Jun 21).
56. Dhore CR, Cleutjens JP, Lutgens E et al. Differential expression of bone matrix regulatory proteins in human atherosclerotic, plaques. Arteriosder Thromb Vasc Biol 2001; 21:1998-2003.
57. Doherty TM, Detrano RC. Coronary arterial calcification as an active process: a new perspective on an old problem. Calcif Tissue Int. 1994; 54:224-30.
58. Shanahan CM, Cary NR, Salisbury JR et al. Medial localization of mineralization-regulating proteins in association with Monckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation. 1999; 100: 2168-76.
59. Stehbens WE. Atherosclerosis and degenerative diseases of blood vessels. In: Stehbens WE, Lie JT, eds. Vascular pathology. London: Chapman and Hall Medical; 1995.
60. Spronk HM, Soute BA, Schurgers LJ et al. Matrix Gla protein accumulates at the border of regions of calcification and normal tissue in the media of the arterial vessel wall. Biochem Biophys Res Commun. 2001; 289:485-90.
61. Farzaneh-Far A, Proudfoot D, Weissberg PL et al. Matrix Gla protein is regulated by a mechanism functionally related to the calcium-sensing receptor. Biochem Biophys Res Commun. 2000; 277:736-40.
62. Geleijnse JM, Vermeer C, Grobbee DL et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam study. J Nutr. 2004; 134:3100-5.
63. Braam LA, Hoeks AP, Brouns F et al. Beneficial effects of vitamins D and K on the elastic properties of the vessel wall in postmenopausal women: a follow-up study. Thromb Haemost. 2004; 91:373-80.
64. Vitamin K monograph. Natural Medicines Comprehensive Database.
65. Vitamin K monograph. Micromedex Healthcare Series. Englewood, CO: Micromedex Inc.
66. McEvoy GK, ed. AHFS drug information. Bethesda, MD: American Society of Health-System Pharmacists; 1998.